Fabrication of Nanoparticles of Gemcitabine and its Derivatives

Name: Fabrication of Nanoparticles of Gemcitabine and its Derivatives
SKU: 23707974
Price: 130.99 AUD
Availability: InStock

By:

Format:

Paperback / softback

Show Hide Adult Content

$130.99

Available from supplier

Usually ships in 3-4 weeks

0 in Trolley

Price Match

Wrap this item as a gift ($5.90) - add a free gift card on the next page

Buy Now, Pay Later with:

4 payments of $32.75 with Afterpay Learn more

Availability

Delivering to:

Estimated arrival:

Around 17-27 June using International Courier

Description

Gemcitabine is a nucleoside analogue, used in various carcinomas such as non small cell lung cancer, pancreatic cancer, ovarian cancer and breast cancer. The major setbacks to the conventional therapy with gemcitabine include its short half-life and highly hydrophilic nature. The objectives of this investigation were to synthesize lipophilic derivative of gemcitabine, evaluate the physiochemical properties, entrapment efficiency, in vitro release, cytotoxicity, and cellular uptake of nanoparticulate formulations containing gemcitabine and stearoyl gemcitabine. We successfully prepared a formulation providing dual protection of gemcitabine against chemical decomposition from plasma catabolism and improve metabolic stability, first by covalently linking the amino group of gemcitabine to a long fatty chain, and then by encapsulating this lipophilic derivative in the formulations. PLGA nanoparticles can act as carriers for both lipophilic and hydrophilic drugs.

Release date Australia

December 19th, 2014

Author

Audience

General (US: Trade)

Pages

100

Dimensions

152x229x6

ISBN-13

9783659666131

Product ID

23707974

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here